There is rising evidence to recommend that anti-ApoA-I autoantibodies perform a immediate part in the pathogenesis of atherosclerosis and CVD and as such must be viewed as as targets for therapeutic intervention
While in this past study immunoreactivity was mentioned to a extended peptide fragment corresponding...